MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility
Author:
Affiliation:
1. Department of Thyroid and Breast
2. General Surgery
3. Shanghai Tenth People's Hospital
4. Tongji University School of Medicine
5. Shanghai 200072
Abstract
Breast cancer is the most frequently diagnosed female cancer.
Funder
National Natural Science Foundation of China
Shanghai Municipal Health Bureau
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2017/RA/C7RA09042K
Reference42 articles.
1. Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies
2. Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications
3. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death
4. Chemotherapy-Resistant Metastatic Breast Cancer
5. Towards a molecular understanding of microRNA-mediated gene silencing
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effect of miR-138 on the proliferation and apoptosis of breast cancer cells through the NF-κB/VEGF signaling pathway;Cellular and Molecular Biology;2022-02-28
2. miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism;Cells;2021-12-22
3. MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers;Oncogene;2021-12-22
4. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery;Genes;2021-08-04
5. MiRNA-138–5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis;European Journal of Pharmacology;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3